Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Efavirenz-induced catatonia.

Sabato S, Wesselingh S, Fuller A, Ray J, Mijch A.

AIDS. 2002 Sep 6;16(13):1841-2. No abstract available.

PMID:
12218403
2.

A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.

Wolbach J, Capoccia K.

Nurse Pract. 1999 Jun;24(6):81-2, 87-90, 92. Review. No abstract available.

PMID:
10431297
3.

Efavirenz-induced photoallergic dermatitis in HIV.

Treudler R, Husak R, Raisova M, Orfanos CE, Tebbe B.

AIDS. 2001 May 25;15(8):1085-6. No abstract available.

PMID:
11400003
4.

Efavirenz-associated breast hypertrophy in HIV-infection patients.

Mercié P, Viallard JF, Thiébaut R, Faure I, Rispal P, Leng B, Pellegrin JL.

AIDS. 2001 Jan 5;15(1):126-9. No abstract available.

PMID:
11192857
5.

[Efavirenz].

Taéron C.

Rev Infirm. 2005 May;(111):37-8. French. No abstract available.

PMID:
15991644
6.

Manic syndrome associated with efavirenz overdose.

Blanch J, Corbella B, García F, Parellada E, Gatell JM.

Clin Infect Dis. 2001 Jul 15;33(2):270-1. No abstract available.

PMID:
11418896
7.

Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.

Caso JA, Prieto Jde M, Casas E, Sanz J.

AIDS. 2001 Jul 27;15(11):1447-8. No abstract available.

PMID:
11504970
8.

Switching from protease inhibitors to the non-nuke efavirenz.

[No authors listed]

TreatmentUpdate. 2001 Spring;12(12):3. No abstract available.

PMID:
11570089
9.

[Neuro-psychiatric adverse effects associated with efavirenz].

Ramírez-Duque N, López-Cortés LF.

Enferm Infecc Microbiol Clin. 2006 Jan;24(1):64-6. Spanish. No abstract available.

PMID:
16537067
10.

Hypersensitivity syndrome associated with efavirenz therapy.

Bossi P, Colin D, Bricaire F, Caumes E.

Clin Infect Dis. 2000 Jan;30(1):227-8. No abstract available.

PMID:
10619772
11.

[Didanosine--stability as backbone drug].

[No authors listed]

MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:83-4. German. No abstract available.

PMID:
16385888
12.
13.

[Valuable combination partner. Great benefit for therapy naive patients].

[No authors listed]

MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:82-4. German. No abstract available.

PMID:
15373061
14.

Non-nucleoside reverse transcriptase inhibitors--an overview.

Bell C, Matthews GV, Nelson MR.

Int J STD AIDS. 2003 Feb;14(2):71-7. Review. No abstract available.

PMID:
12662384
15.

Four-drug regimens may be better.

[No authors listed]

AIDS Patient Care STDS. 2000 Dec;14(12):671. No abstract available.

PMID:
11119435
16.

Myelomeningocele in a child with intrauterine exposure to efavirenz.

Fundarò C, Genovese O, Rendeli C, Tamburrini E, Salvaggio E.

AIDS. 2002 Jan 25;16(2):299-300. No abstract available. Erratum in: AIDS. 2002 Jul 5;16(10):1443..

PMID:
11807320
17.

Reply. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs.

Gonzalez A, Everall I.

AIDS. 1999 Oct 1;13(14):1996. No abstract available.

PMID:
10513671
18.

Efavirenz decreases methadone blood concentrations.

Marzolini C, Troillet N, Telenti A, Baumann P, Decosterd LA, Eap CB.

AIDS. 2000 Jun 16;14(9):1291-2. No abstract available.

PMID:
10894303
19.

Cortisol serum levels and their relationship to certain antiretroviral drugs.

Collazos J, Ibarra S, Loureiro M.

Scand J Infect Dis. 2004;36(6-7):480-2.

PMID:
15307572
20.

[Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor].

[No authors listed]

MMW Fortschr Med. 2001 Apr 2;143 Suppl 1:39. German. No abstract available.

PMID:
11373776

Supplemental Content

Support Center